Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q3 FY25 results · Oct–Dec 2024
Medplus Health Services reported revenue from operations of ₹1,561.45 crore (up 8.3% from Q3 FY24) and net profit of ₹45.87 crore (up 234.7% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,561.45 | 1,441.47 | +8.3% | 1,576.17 | −0.9% |
| Other income | 12.52 | 9.79 | +27.8% | 11.60 | +7.9% |
| Total income | 1,573.96 | 1,451.26 | +8.5% | 1,587.77 | −0.9% |
| Profit before tax | 56.60 | 19.96 | +183.5% | 47.78 | +18.4% |
| Net profit for the period | 45.87 | 13.71 | +234.7% | 38.70 | +18.5% |
| Attributable to shareholders of the company | 45.89 | 13.73 | +234.3% | 38.74 | +18.5% |
| EPS, basic (₹) | 3.84 | 1.15 | +233.9% | 3.24 | +18.5% |
| Net margin (%) | 2.9 | 1.0 | 2.5 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 176.79 | 148.10 | +19.4% | 156.23 | +13.2% |
| Other income | 2.19 | 1.82 | +20.1% | 2.25 | −2.7% |
| Total income | 178.98 | 149.92 | +19.4% | 158.48 | +12.9% |
| Profit before tax | 12.03 | 4.24 | +183.6% | 9.64 | +24.8% |
| Net profit for the period | 9.37 | 3.19 | +193.9% | 7.75 | +20.9% |
| EPS, basic (₹) | 0.78 | 0.27 | +188.9% | 0.65 | +20.0% |
| Net margin (%) | 5.3 | 2.2 | 5.0 |
Consolidated
- Filed with BSE
- 31 Jan 2025, 19:35 IST
- Board meeting
- 31 Jan 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 31 Jan 2025, 19:35 IST
- Board meeting
- 31 Jan 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE